SONOVA HLDG AG/ADR (OTCMKTS:SONVY) and Fonar (NASDAQ:FONR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.
This is a breakdown of current recommendations and price targets for SONOVA HLDG AG/ADR and Fonar, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|SONOVA HLDG AG/ADR||0||0||1||0||3.00|
Volatility & Risk
SONOVA HLDG AG/ADR has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Fonar has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.
This table compares SONOVA HLDG AG/ADR and Fonar’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|SONOVA HLDG AG/ADR||N/A||N/A||N/A|
Insider and Institutional Ownership
0.2% of SONOVA HLDG AG/ADR shares are owned by institutional investors. Comparatively, 52.3% of Fonar shares are owned by institutional investors. 3.0% of Fonar shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
SONOVA HLDG AG/ADR pays an annual dividend of $0.30 per share and has a dividend yield of 0.8%. Fonar does not pay a dividend. SONOVA HLDG AG/ADR pays out 22.9% of its earnings in the form of a dividend.
Earnings and Valuation
This table compares SONOVA HLDG AG/ADR and Fonar’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|SONOVA HLDG AG/ADR||$2.73 billion||4.38||$412.45 million||$1.31||27.89|
|Fonar||$81.52 million||1.75||$21.23 million||N/A||N/A|
SONOVA HLDG AG/ADR has higher revenue and earnings than Fonar.
Fonar beats SONOVA HLDG AG/ADR on 7 of the 13 factors compared between the two stocks.
About SONOVA HLDG AG/ADR
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological care services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; and professional hearing care services under the AudioNova, Audium, AuditionSanté, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton, and Vitakustik brands. Sonova Holding operates through sales channels, including independent healthcare professionals, government agencies, clinics, and retail network, as well as through Sonova-owned wholesale companies and independent distributors. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
FONAR Corporation, together with its subsidiaries, operates as a magnetic resonance imaging (MRI) company primarily in the Unites States. It is involved in the research, development, production, and marketing of medical scanning equipment, which uses principles of MRI for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries. The company operates in two segments, Manufacturing and Servicing of Medical Equipment, and Management of Diagnostic Imaging Centers. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company markets its scanners to private diagnostic imaging centers and hospitals. It also provides non-medical management services, including development, administration, office space leasing, facilities, equipment, supplies, staffing, credentialing, accounting, billing and collection, assistance with compliance matters, and practice growth and marketing strategies development and implementation services, as well as engages in the training and supervision of non-medical personnel for diagnostic imaging facilities. The company also exports its products to the United Arab Emirates, Switzerland, Canada, England, Germany, and Puerto Rico. It owns and operates 4 diagnostic imaging facilities in Florida; and manages 26 MRI scanning facilities, including 19 facilities located in New York and 7 situated in Florida. The company was founded in 1978 and is based in Melville, New York.
Receive News & Ratings for SONOVA HLDG AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SONOVA HLDG AG/ADR and related companies with MarketBeat.com's FREE daily email newsletter.